Patent US5169787A successfully refreshed from Google Patents.
US5169787A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Test carrier for determining an analyte in a blood sample, process for making the carrier and use thereof
Assignee: Roche Diagnostics GmbH
•
Filing: 1988-07-27
•
Granted: 1992-12-08
•
Expires: 2008-07-27
Abstract
Abstract The present invention provides a test carrier for the determination of an analyte from whole blood with the help of reagents contained in the test carrier, said test carrier having a blood application side to which blood is applied, an evaluation side on which, as a result of the reaction of the reagents with the analyte, an optically detectable change takes place, and an erythrocyte separation means between the blood application side and the evaluation side, wherein the erythrocyte separation means includes an integral composite having a first zone, which contains a polymeric film former, kieselguhr and a pigment, and thereupon, with formation of a transition region, a second zone containing a polymeric film-former, formed by liquid coating the first zone facing the blood application side and the second zone facing the evaluation side of the integral composite. The present invention also provides a process for the production of this test carrier and a method for analyzing blood samples using it.
Inventors
- 👤 Wolfgang-Reinhold Knappe
- 👤 Dieter Scheithauer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 10:25
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/52; G01N33/525
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
151 words
Test carrier for determination of an analyte in a whole blood sample comprising a two sided erythrocyte separation means, a first side of said erythrocyte separation means being in fluid communication with a means for the application of blood and a second side of said erythrocyte separation means being in fluid communication with an evaluation means, said erythrocyte separation means comprising an integral composite structure having a first zone, a second zone and a transition region between said first and second zones, said first zone containing a polymeric film former, kieselguhr and a pigment, said first zone having applied thereon said second zone containing a liquid coated polymeric film former thereby forming said transition region of said integral composite structure between said first and second zones, said first zone of said erythrocyte separation means facing said first side and said second zone of said erythrocyte separation means facing said second side.
Claim 2
Dependent Claim
151 words
Test carrier for determination of an analyte in a whole blood sample comprising a two sided erythrocyte separation means, a first side of said erythrocyte separation means being in fluid communication with a means for the application of blood and a second side of said erythrocyte separation means being in fluid communication with an evaluation means, said erythrocyte separation means comprising an integral composite structure having a first zone, a second zone and a transition region between said first and second zones, said first zone containing a polymeric film former, kieselguhr and a pigment, said first zone having applied thereon said second zone containing a liquid coated polymeric film former thereby forming said transition region of said integral composite structure between said first and second zones, said first zone of said erythrocyte separation means facing said first side and said second zone of said erythrocyte separation means facing said second side.
Claim 3
Dependent Claim
35 words
Test carrier of claim 1, wherein said integral composite structure further comprises a porous support layer to which said first zone is fixed, said support layer facing said first side of said erythrocyte separation means.
Claim 4
Dependent Claim
27 words
Test carrier of claim 1, wherein at least one of the polymeric film former of said first zone and said second zone is a dispersion film former.
Claim 5
Dependent Claim
19 words
Test carrier of claim 1, wherein said kieselguhr has an average particle diameter of from 5 to 15 um.
Claim 6
Dependent Claim
19 words
Test carrier of claim 1, wherein said pigment has an average particle diameter of from 0.2 to 0.7 um.
Claim 7
Dependent Claim
25 words
Test carrier of claim 1, wherein said kieselguhr and said pigment in said first zone are in a weight ratio of from 1:0.5 to 1:2.
Claim 8
Dependent Claim
27 words
Test carrier of claim 1, wherein said kieselguhr and said polymeric film former of said first zone are in a weight ratio of from 1:0.2 to 1:0.9.
Claim 9
Dependent Claim
18 words
Test carrier of claim 1, wherein said integral composite structure has a thickness of up to 0.6 mm.
Claim 10
Dependent Claim
18 words
Test carrier of claim 1, wherein said integral composite structure has a thickness of up to 0.2 mm.
Claim 11
Dependent Claim
159 words
Process for producing a test carrier for determining an analyte in a sample of whole blood, comprising: forming a first zone of an integral composite structure by applying a first flowable coating mass to a substrate base, said first coating mass containing a solution or dispersion of a polymeric film former in a carrier liquid, kieselguhr, a pigment and an adjuvant and drying said first coating mass to form a first zone on said substrate base, applying a second coating mass containing a solution or dispersion of a polymeric film former to said film to form a second zone, said first zone and second zone forming an integral composite structure with a transition region formed therebetween, and positioning said laminated composite structure in a test carrier such that the first zone is in fluid communication with a blood application means of said carrier and the second zone is in fluid communication with an evaluation means of said test carrier.
Claim 12
Dependent Claim
159 words
Process for producing a test carrier for determining an analyte in a sample of whole blood, comprising: forming a first zone of an integral composite structure by applying a first flowable coating mass to a substrate base, said first coating mass containing a solution or dispersion of a polymeric film former in a carrier liquid, kieselguhr, a pigment and an adjuvant and drying said first coating mass to form a first zone on said substrate base, applying a second coating mass containing a solution or dispersion of a polymeric film former to said film to form a second zone, said first zone and second zone forming an integral composite structure with a transition region formed therebetween, and positioning said laminated composite structure in a test carrier such that the first zone is in fluid communication with a blood application means of said carrier and the second zone is in fluid communication with an evaluation means of said test carrier.
Claim 13
Dependent Claim
14 words
Process of claim 10, wherein said substrate base is made of a porous material.
Claim 14
Dependent Claim
25 words
Process of claim 10, wherein said second coating mass further comprises a component which produces an optically detectable signal in a reaction involving said analyte.
Claim 15
Dependent Claim
29 words
Process of claim 10, wherein said first coating mass has a viscosity of 300 to 3000 millipascal seconds at a shear gradient of 492s -1 according to DIN 53019.
Claim 16
Dependent Claim
30 words
Process of claim 10, wherein said second coating mass has a viscosity of 10 to 1000 millipascal seconds at a shear gradient of 492 s -1 according to DIN 53019.
Claim 17
Dependent Claim
24 words
Process according to claim 10, wherein said second layer has a maximum weight of 100 g of polymeric film former per m 2 .
Claim 18
Dependent Claim
37 words
Method for determining an analyte in a whole blood sample comprising contacting said sample with a test carrier of claim 1 and determining a reaction between a reagent and said analyte as an indication of said analyte.
References Cited (Backward Citations)
US3663374A
Cited
US3791933A
Cited
US4256693A
Cited
US4255384A
Cited
EP0016387A1
Cited
US4312834A
Cited
US4477575A
Cited
US4477575B1
Cited
DE3237233A1
Cited
US4613567A
Cited
WO1984002192A1
Cited
US4820489A
Cited
US4604264A
Cited
US4459358A
Cited
EP0226767A2
Cited
EP0271854A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-12-08 | 1996-06-08 | 1996-12-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-12-08 | 2000-06-08 | 2000-12-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-12-08 | 2004-06-08 | 2004-12-08 | $7700.00 | Window Closed / Lapsed |